Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
| Autor: | Kunle O. Odusi, K.S. Grzankowski, Rachel Brightwell, John Kasznica |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Oncology
medicine.medical_specialty Case Report Pemetrexed medicine.disease_cause lcsh:Gynecology and obstetrics lcsh:RC254-282 Asbestos Internal medicine Medicine lcsh:RG1-991 Cisplatin HIPEC business.industry Obstetrics and Gynecology lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens medicine.disease 3. Good health Malignant Peritoneal Mesothelioma Peritoneal mesothelioma business Ovarian cancer medicine.drug |
| Zdroj: | Gynecologic Oncology Reports Gynecologic Oncology Reports, Vol 11, Iss C, Pp 10-12 (2015) |
| ISSN: | 2352-5789 |
| DOI: | 10.1016/j.gore.2014.11.002 |
| Popis: | Highlights • Malignant peritoneal mesothelioma is a rare aggressive tumor with approximately 400 new cases annually in the US. • In optimal cytoreduction HIPEC is the standard treatment. • In suboptimal cytoreduction IV cisplatin and pemetrexed have high efficacy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|